{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:21:55Z","timestamp":1794900115136,"version":"4.9.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pancreatic ductal adenocarcinoma (PDAC) is one of the most deadly malignancies with &lt;5% five-year survival rate due to late diagnosis, limited treatment options and chemoresistance. There is thus an urgent unmet clinical need to develop effective anticancer drugs to treat pancreatic cancer. Here, we study the potential of repurposing monensin as an anticancer drug for chemo-resistant pancreatic cancer. Using the two commonly-used chemo-resistant pancreatic cancer cell lines PANC-1 and MiaPaCa-2, we show that monensin suppresses cell proliferation and migration, and cell cycle progression, while solicits apoptosis in pancreatic cancer lines at a low micromole range. Moreover, monensin functions synergistically with gemcitabine or EGFR inhibitor erlotinib in suppressing cell growth and inducing cell death of pancreatic cancer cells. Mechanistically, monensin suppresses numerous cancer-associated pathways, such as E2F\/DP1, STAT1\/2, NFkB, AP-1, Elk-1\/SRF, and represses EGFR expression in pancreatic cancer lines. Furthermore, the <jats:italic>in vivo<\/jats:italic> study shows that monensin blunts PDAC xenograft tumor growth by suppressing cell proliferation via targeting EGFR pathway. Therefore, our findings demonstrate that monensin can be repurposed as an effective anti-pancreatic cancer drug even\u00a0though more investigations are needed to validate its safety and anticancer efficacy in pre-clinical and clinical models.<\/jats:p>","DOI":"10.1038\/s41598-018-36214-5","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T18:22:17Z","timestamp":1544552537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway"],"prefix":"10.1038","volume":"8","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex C.","family":"Haydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hue H.","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Chuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"key":"36214_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3322\/caac.21190","volume":"63","author":"CL Wolfgang","year":"2013","unstructured":"Wolfgang, C. L. et al. Recent progress in pancreatic cancer. CA Cancer J Clin 63, 318\u2013348, https:\/\/doi.org\/10.3322\/caac.21190 (2013).","journal-title":"CA Cancer J Clin"},{"key":"36214_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.gendis.2015.01.002","volume":"2","author":"D Xie","year":"2015","unstructured":"Xie, D. & Xie, K. Pancreatic cancer stromal biology and therapy. Genes Dis 2, 133\u2013143, https:\/\/doi.org\/10.1016\/j.gendis.2015.01.002 (2015).","journal-title":"Genes Dis"},{"key":"36214_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J Clin 68, 7\u201330, https:\/\/doi.org\/10.3322\/caac.21442 (2018).","journal-title":"CA Cancer J Clin"},{"key":"36214_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa, T., Wood, L. D., Itoi, T. & Takaori, K. Pancreatic cancer. Lancet 388, 73\u201385, https:\/\/doi.org\/10.1016\/S0140-6736(16)00141-0 (2016).","journal-title":"Lancet"},{"key":"36214_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMra0901557","volume":"362","author":"M Hidalgo","year":"2010","unstructured":"Hidalgo, M. Pancreatic cancer. N Engl J Med 362, 1605\u20131617, https:\/\/doi.org\/10.1056\/NEJMra0901557 (2010).","journal-title":"N Engl J Med"},{"key":"36214_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrgastro.2009.177","volume":"6","author":"S Raimondi","year":"2009","unstructured":"Raimondi, S., Maisonneuve, P. & Lowenfels, A. B. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 6, 699\u2013708, https:\/\/doi.org\/10.1038\/nrgastro.2009.177 (2009).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"36214_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J Clin 66, 115\u2013132, https:\/\/doi.org\/10.3322\/caac.21338 (2016).","journal-title":"CA Cancer J Clin"},{"key":"36214_CR8","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74, 2913\u20132921, https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155 (2014).","journal-title":"Cancer Res"},{"key":"36214_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.drup.2015.10.002","volume":"23","author":"Y Binenbaum","year":"2015","unstructured":"Binenbaum, Y., Na\u2019ara, S. & Gil, Z. Gemcitabine resistance in pancreatic ductal adenocarcinoma. Drug Resist Updat 23, 55\u201368, https:\/\/doi.org\/10.1016\/j.drup.2015.10.002 (2015).","journal-title":"Drug Resist Updat"},{"key":"36214_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352, https:\/\/doi.org\/10.1038\/nature16965 (2016).","journal-title":"Nature"},{"key":"36214_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pan.2016.12.013","volume":"17","author":"A Rajabpour","year":"2017","unstructured":"Rajabpour, A., Rajaei, F. & Teimoori-Toolabi, L. Molecular alterations contributing to pancreatic cancer chemoresistance. Pancreatology 17, 310\u2013320, https:\/\/doi.org\/10.1016\/j.pan.2016.12.013 (2017).","journal-title":"Pancreatology"},{"key":"36214_CR12","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"HA Burris 3rd","year":"1997","unstructured":"Burris, H. A. 3rd et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15, 2403\u20132413, https:\/\/doi.org\/10.1200\/JCO.1997.15.6.2403 (1997).","journal-title":"J Clin Oncol"},{"key":"36214_CR13","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","volume":"25","author":"MJ Moore","year":"2007","unstructured":"Moore, M. J. et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25, 1960\u20131966, https:\/\/doi.org\/10.1200\/JCO.2006.07.9525 (2007).","journal-title":"J Clin Oncol"},{"key":"36214_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","volume":"124","author":"L Sleire","year":"2017","unstructured":"Sleire, L. et al. Drug repurposing in cancer. Pharmacol Res 124, 74\u201391, https:\/\/doi.org\/10.1016\/j.phrs.2017.07.013 (2017).","journal-title":"Pharmacol Res"},{"key":"36214_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.trecan.2017.06.007","volume":"3","author":"C Verbaanderd","year":"2017","unstructured":"Verbaanderd, C., Meheus, L., Huys, I. & Pantziarka, P. Repurposing Drugs in Oncology: Next Steps. Trends Cancer 3, 543\u2013546, https:\/\/doi.org\/10.1016\/j.trecan.2017.06.007 (2017).","journal-title":"Trends Cancer"},{"key":"36214_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","volume":"34","author":"SC Gupta","year":"2013","unstructured":"Gupta, S. C., Sung, B., Prasad, S., Webb, L. J. & Aggarwal, B. B. Cancer drug discovery by repurposing: teaching new tricks to old dogs. Trends Pharmacol Sci 34, 508\u2013517, https:\/\/doi.org\/10.1016\/j.tips.2013.06.005 (2013).","journal-title":"Trends Pharmacol Sci"},{"key":"36214_CR17","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.2174\/1568026616666160216153618","volume":"16","author":"D Bhattarai","year":"2016","unstructured":"Bhattarai, D. et al. An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs. Curr Top Med Chem 16, 2156\u20132168 (2016).","journal-title":"Curr Top Med Chem"},{"key":"36214_CR18","first-page":"1283","volume":"27","author":"BC Pressman","year":"1968","unstructured":"Pressman, B. C. Ionophorous antibiotics as models for biological transport. Fed Proc 27, 1283\u20131288 (1968).","journal-title":"Fed Proc"},{"key":"36214_CR19","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1158\/1535-7163.MCT-13-1086","volume":"13","author":"K Dayekh","year":"2014","unstructured":"Dayekh, K. et al. Monensin inhibits epidermal growth factor receptor trafficking and activation: synergistic cytotoxicity in combination with EGFR inhibitors. Mol Cancer Ther 13, 2559\u20132571, https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-1086 (2014).","journal-title":"Mol Cancer Ther"},{"key":"36214_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.diff.2009.06.001","volume":"78","author":"GH Zhu","year":"2009","unstructured":"Zhu, G. H. et al. Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 78, 195\u2013204, https:\/\/doi.org\/10.1016\/j.diff.2009.06.001 (2009).","journal-title":"Differentiation"},{"key":"36214_CR21","doi-asserted-by":"publisher","first-page":"e32428","DOI":"10.1371\/journal.pone.0032428","volume":"7","author":"E Huang","year":"2012","unstructured":"Huang, E. et al. Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential. PLoS One 7, e32428, https:\/\/doi.org\/10.1371\/journal.pone.0032428 (2012).","journal-title":"PLoS One"},{"key":"36214_CR22","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/jbmr.1622","volume":"27","author":"E Huang","year":"2012","unstructured":"Huang, E. et al. Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK\/STAT\/IGF1 pathway in murine multilineage cells. J Bone Miner Res 27, 1566\u20131575, https:\/\/doi.org\/10.1002\/jbmr.1622 (2012).","journal-title":"J Bone Miner Res"},{"key":"36214_CR23","first-page":"975","volume":"32","author":"X Luo","year":"2008","unstructured":"Luo, X. et al. Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. Int J Oncol 32, 975\u2013983 (2008).","journal-title":"Int J Oncol"},{"key":"36214_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3727\/096368914X681054","volume":"24","author":"JD Lamplot","year":"2015","unstructured":"Lamplot, J. D. et al. Reversibly Immortalized Mouse Articular Chondrocytes Acquire Long-Term Proliferative Capability While Retaining Chondrogenic Phenotype. Cell Transplant 24, 1053\u20131066, https:\/\/doi.org\/10.3727\/096368914X681054 (2015).","journal-title":"Cell Transplant"},{"key":"36214_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.gendis.2017.10.004","volume":"4","author":"C Zhao","year":"2017","unstructured":"Zhao, C. et al. Sox9 augments BMP2-induced chondrogenic differentiation by downregulating Smad7 in mesenchymal stem cells (MSCs). Genes Dis 4, 229\u2013239, https:\/\/doi.org\/10.1016\/j.gendis.2017.10.004 (2017).","journal-title":"Genes Dis"},{"key":"36214_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10585-009-9259-6","volume":"26","author":"Y Su","year":"2009","unstructured":"Su, Y. et al. Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin Exp Metastasis 26, 599\u2013610, https:\/\/doi.org\/10.1007\/s10585-009-9259-6 (2009).","journal-title":"Clin Exp Metastasis"},{"key":"36214_CR27","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1111\/jcmm.13193","volume":"21","author":"D Song","year":"2017","unstructured":"Song, D. et al. BMP9 induces osteogenesis and adipogenesis in the immortalized human cranial suture progenitors from the patent sutures of craniosynostosis patients. J Cell Mol Med 21, 2782\u20132795, https:\/\/doi.org\/10.1111\/jcmm.13193 (2017).","journal-title":"J Cell Mol Med"},{"key":"36214_CR28","doi-asserted-by":"publisher","first-page":"12968","DOI":"10.18632\/oncotarget.14673","volume":"8","author":"F Zhang","year":"2017","unstructured":"Zhang, F. et al. Anthelmintic mebendazole enhances cisplatin\u2019s effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC). Oncotarget 8, 12968\u201312982, https:\/\/doi.org\/10.18632\/oncotarget.14673 (2017).","journal-title":"Oncotarget"},{"key":"36214_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep17523","volume":"5","author":"Y Deng","year":"2015","unstructured":"Deng, Y. et al. Antibiotic monensin synergizes with EGFR inhibitors and oxaliplatin to suppress the proliferation of human ovarian cancer cells. Sci Rep 5, 17523, https:\/\/doi.org\/10.1038\/srep17523 (2015).","journal-title":"Sci Rep"},{"key":"36214_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.gendis.2014.12.001","volume":"2","author":"X Chen","year":"2015","unstructured":"Chen, X. et al. Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system. Genes Dis 2, 96\u2013105, https:\/\/doi.org\/10.1016\/j.gendis.2014.12.001 (2015).","journal-title":"Genes Dis"},{"key":"36214_CR31","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.7150\/ijms.6639","volume":"10","author":"M Li","year":"2013","unstructured":"Li, M. et al. Establishment and characterization of the reversibly immortalized mouse fetal heart progenitors. Int J Med Sci 10, 1035\u20131046, https:\/\/doi.org\/10.7150\/ijms.6639 (2013).","journal-title":"Int J Med Sci"},{"key":"36214_CR32","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1128\/MCB.26.8.2955-2964.2006","volume":"26","author":"W Si","year":"2006","unstructured":"Si, W. et al. CCN1\/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26, 2955\u20132964, https:\/\/doi.org\/10.1128\/MCB.26.8.2955-2964.2006 (2006).","journal-title":"Mol Cell Biol"},{"key":"36214_CR33","doi-asserted-by":"publisher","first-page":"726","DOI":"10.2174\/1568009615666150629132157","volume":"15","author":"Z Liao","year":"2015","unstructured":"Liao, Z. et al. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways. Curr Cancer Drug Targets 15, 726\u2013738 (2015).","journal-title":"Curr Cancer Drug Targets"},{"key":"36214_CR34","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/1568009614666140305105805","volume":"14","author":"R Li","year":"2014","unstructured":"Li, R. et al. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling. Curr Cancer Drug Targets 14, 274\u2013285 (2014).","journal-title":"Curr Cancer Drug Targets"},{"key":"36214_CR35","doi-asserted-by":"publisher","first-page":"e14182","DOI":"10.1371\/journal.pone.0014182","volume":"5","author":"F Rastegar","year":"2010","unstructured":"Rastegar, F. et al. Lysophosphatidic acid acyltransferase beta (LPAATbeta) promotes the tumor growth of human osteosarcoma. PLoS One 5, e14182, https:\/\/doi.org\/10.1371\/journal.pone.0014182 (2010).","journal-title":"PLoS One"},{"key":"36214_CR36","doi-asserted-by":"publisher","first-page":"55958","DOI":"10.1074\/jbc.M407810200","volume":"279","author":"Q Luo","year":"2004","unstructured":"Luo, Q. et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279, 55958\u201355968, https:\/\/doi.org\/10.1074\/jbc.M407810200 (2004).","journal-title":"J Biol Chem"},{"key":"36214_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.canlet.2005.02.015","volume":"229","author":"HH Luu","year":"2005","unstructured":"Luu, H. H. et al. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett 229, 135\u2013148, https:\/\/doi.org\/10.1016\/j.canlet.2005.02.015 (2005).","journal-title":"Cancer Lett"},{"key":"36214_CR38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2013.05.002","volume":"336","author":"GA Luther","year":"2013","unstructured":"Luther, G. A. et al. IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma. Cancer Lett 336, 222\u2013230, https:\/\/doi.org\/10.1016\/j.canlet.2013.05.002 (2013).","journal-title":"Cancer Lett"},{"key":"36214_CR39","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1159\/000438591","volume":"37","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation. Cell Physiol Biochem 37, 2375\u20132392, https:\/\/doi.org\/10.1159\/000438591 (2015).","journal-title":"Cell Physiol Biochem"},{"key":"36214_CR40","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1159\/000366340","volume":"34","author":"Y Bi","year":"2014","unstructured":"Bi, Y. et al. Functional characteristics of reversibly immortalized hepatic progenitor cells derived from mouse embryonic liver. Cell Physiol Biochem 34, 1318\u20131338, https:\/\/doi.org\/10.1159\/000366340 (2014).","journal-title":"Cell Physiol Biochem"},{"key":"36214_CR41","doi-asserted-by":"publisher","first-page":"e94397","DOI":"10.1371\/journal.pone.0094397","volume":"9","author":"S Wen","year":"2014","unstructured":"Wen, S. et al. Characterization of constitutive promoters for piggyBac transposon-mediated stable transgene expression in mesenchymal stem cells (MSCs). PLoS One 9, e94397, https:\/\/doi.org\/10.1371\/journal.pone.0094397 (2014).","journal-title":"PLoS One"},{"key":"36214_CR42","doi-asserted-by":"publisher","first-page":"29588","DOI":"10.1074\/jbc.M110.130518","volume":"285","author":"J Luo","year":"2010","unstructured":"Luo, J. et al. TGFbeta\/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J Biol Chem 285, 29588\u201329598, https:\/\/doi.org\/10.1074\/jbc.M110.130518 (2010).","journal-title":"J Biol Chem"},{"key":"36214_CR43","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1159\/000354508","volume":"32","author":"X Chen","year":"2013","unstructured":"Chen, X. et al. The E-F hand calcium-binding protein S100A4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. Cell Physiol Biochem 32, 1083\u20131096, https:\/\/doi.org\/10.1159\/000354508 (2013).","journal-title":"Cell Physiol Biochem"},{"key":"36214_CR44","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1158\/1078-0432.CCR-09-2499","volume":"16","author":"BC He","year":"2010","unstructured":"He, B. C. et al. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res 16, 2235\u20132245, https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2499 (2010).","journal-title":"Clin Cancer Res"},{"key":"36214_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1124\/mol.110.068668","volume":"79","author":"BC He","year":"2011","unstructured":"He, B. C. et al. Tetrandrine inhibits Wnt\/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 79, 211\u2013219, https:\/\/doi.org\/10.1124\/mol.110.068668 (2011).","journal-title":"Mol Pharmacol"},{"key":"36214_CR46","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1002\/jbma.35006","volume":"102","author":"W Shui","year":"2014","unstructured":"Shui, W. et al. Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration. J Biomed Mater Res A 102, 3429\u20133438, https:\/\/doi.org\/10.1002\/jbma.35006 (2014).","journal-title":"J Biomed Mater Res A"},{"key":"36214_CR47","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1038\/jid.2012.145","volume":"132","author":"K Yang","year":"2012","unstructured":"Yang, K. et al. Conditional immortalization establishes a repertoire of mouse melanocyte progenitors with distinct melanogenic differentiation potential. J Invest Dermatol 132, 2479\u20132483, https:\/\/doi.org\/10.1038\/jid.2012.145 (2012).","journal-title":"J Invest Dermatol"},{"key":"36214_CR48","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou, T. C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58, 621\u2013681, https:\/\/doi.org\/10.1124\/pr.58.3.10 (2006).","journal-title":"Pharmacol Rev"},{"key":"36214_CR49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70, 440\u2013446, https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1947 (2010).","journal-title":"Cancer Res"},{"key":"36214_CR50","doi-asserted-by":"publisher","first-page":"27105","DOI":"10.18632\/oncotarget.15637","volume":"8","author":"J Fan","year":"2017","unstructured":"Fan, J. et al. Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors. Oncotarget 8, 27105\u201327119, https:\/\/doi.org\/10.18632\/oncotarget.15637 (2017).","journal-title":"Oncotarget"},{"key":"36214_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biomaterials.2014.11.007","volume":"39","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Canonical Wnt signaling acts synergistically on BMP9-induced osteo\/odontoblastic differentiation of stem cells of dental apical papilla (SCAPs). Biomaterials 39, 145\u2013154, https:\/\/doi.org\/10.1016\/j.biomaterials.2014.11.007 (2015).","journal-title":"Biomaterials"},{"key":"36214_CR52","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3892\/or.2013.2438","volume":"30","author":"JL Gao","year":"2013","unstructured":"Gao, J. L. et al. Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways. Oncol Rep 30, 292\u2013298, https:\/\/doi.org\/10.3892\/or.2013.2438 (2013).","journal-title":"Oncol Rep"},{"key":"36214_CR53","doi-asserted-by":"publisher","first-page":"025021","DOI":"10.1088\/1748-6041\/11\/2\/025021","volume":"11","author":"J Ye","year":"2016","unstructured":"Ye, J. et al. A thermoresponsive polydiolcitrate-gelatin scaffold and delivery system mediates effective bone formation from BMP9-transduced mesenchymal stem cells. Biomed Mater 11, 025021, https:\/\/doi.org\/10.1088\/1748-6041\/11\/2\/025021 (2016).","journal-title":"Biomed Mater"},{"key":"36214_CR54","doi-asserted-by":"publisher","first-page":"15922","DOI":"10.1021\/acsami.7b00272","volume":"9","author":"Y Zou","year":"2017","unstructured":"Zou, Y. et al. Gelatin-Derived Graphene-Silicate Hybrid Materials Are Biocompatible and Synergistically Promote BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells. ACS Appl Mater Interfaces 9, 15922\u201315932, https:\/\/doi.org\/10.1021\/acsami.7b00272 (2017).","journal-title":"ACS Appl Mater Interfaces"},{"key":"36214_CR55","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser, A. et al. Primer3\u2013new capabilities and interfaces. Nucleic Acids Res 40, e115, https:\/\/doi.org\/10.1093\/nar\/gks596 (2012).","journal-title":"Nucleic Acids Res"},{"key":"36214_CR56","doi-asserted-by":"publisher","first-page":"e0132666","DOI":"10.1371\/journal.pone.0132666","volume":"10","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. TqPCR: A Touchdown qPCR Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green qPCR. PLoS One 10, e0132666, https:\/\/doi.org\/10.1371\/journal.pone.0132666 (2015).","journal-title":"PLoS One"},{"key":"36214_CR57","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/gt.2017.24","volume":"24","author":"J Liao","year":"2017","unstructured":"Liao, J. et al. Characterization of retroviral infectivity and superinfection resistance during retrovirus-mediated transduction of mammalian cells. Gene Ther 24, 333\u2013341, https:\/\/doi.org\/10.1038\/gt.2017.24 (2017).","journal-title":"Gene Ther"},{"key":"36214_CR58","first-page":"3710","volume":"8","author":"S Lu","year":"2016","unstructured":"Lu, S. et al. Bone morphogenetic protein 9 (BMP9) induces effective bone formation from reversibly immortalized multipotent adipose-derived (iMAD) mesenchymal stem cells. Am J Transl Res 8, 3710\u20133730 (2016).","journal-title":"Am J Transl Res"},{"key":"36214_CR59","doi-asserted-by":"publisher","first-page":"e93608","DOI":"10.1371\/journal.pone.0093608","volume":"9","author":"N Wang","year":"2014","unstructured":"Wang, N. et al. Adenovirus-mediated efficient gene transfer into cultured three-dimensional organoids. PLoS One 9, e93608, https:\/\/doi.org\/10.1371\/journal.pone.0093608 (2014).","journal-title":"PLoS One"},{"key":"36214_CR60","doi-asserted-by":"publisher","first-page":"e97316","DOI":"10.1371\/journal.pone.0097316","volume":"9","author":"N Wang","year":"2014","unstructured":"Wang, N. et al. The piggyBac transposon-mediated expression of SV40 T antigen efficiently immortalizes mouse embryonic fibroblasts (MEFs). PLoS One 9, e97316, https:\/\/doi.org\/10.1371\/journal.pone.0097316 (2014).","journal-title":"PLoS One"},{"key":"36214_CR61","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/j.1582-4934.2008.00569.x","volume":"13","author":"N Tang","year":"2009","unstructured":"Tang, N. et al. BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt\/beta-catenin signalling. J Cell Mol Med 13, 2448\u20132464, https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00569.x (2009).","journal-title":"J Cell Mol Med"},{"key":"36214_CR62","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10585-005-0365-9","volume":"22","author":"HH Luu","year":"2005","unstructured":"Luu, H. H. et al. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22, 319\u2013329, https:\/\/doi.org\/10.1007\/s10585-005-0365-9 (2005).","journal-title":"Clin Exp Metastasis"},{"key":"36214_CR63","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/labinvest.2008.98","volume":"88","author":"X Luo","year":"2008","unstructured":"Luo, X. et al. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 88, 1264\u20131277, https:\/\/doi.org\/10.1038\/labinvest.2008.98 (2008).","journal-title":"Lab Invest"},{"key":"36214_CR64","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1007\/s11999-008-0361-x","volume":"466","author":"X Luo","year":"2008","unstructured":"Luo, X., Sharff, K. A., Chen, J., He, T. C. & Luu, H. H. S100A6 expression and function in human osteosarcoma. Clin Orthop Relat Res 466, 2060\u20132070, https:\/\/doi.org\/10.1007\/s11999-008-0361-x (2008).","journal-title":"Clin Orthop Relat Res"},{"key":"36214_CR65","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1159\/000490140","volume":"47","author":"X Yu","year":"2018","unstructured":"Yu, X. et al. Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells. Cell Physiol Biochem 47, 957\u2013971, https:\/\/doi.org\/10.1159\/000490140 (2018).","journal-title":"Cell Physiol Biochem"},{"key":"36214_CR66","doi-asserted-by":"publisher","first-page":"111847","DOI":"10.18632\/oncotarget.22915","volume":"8","author":"X Hu","year":"2017","unstructured":"Hu, X. et al. CRISPR\/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs). Oncotarget 8, 111847\u2013111865, https:\/\/doi.org\/10.18632\/oncotarget.22915 (2017).","journal-title":"Oncotarget"},{"key":"36214_CR67","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1159\/000456885","volume":"41","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. NEL-Like Molecule-1 (Nell1) Is Regulated by Bone Morphogenetic Protein 9 (BMP9) and Potentiates BMP9-Induced Osteogenic Differentiation at the Expense of Adipogenesis in Mesenchymal Stem Cells. Cell Physiol Biochem 41, 484\u2013500, https:\/\/doi.org\/10.1159\/000456885 (2017).","journal-title":"Cell Physiol Biochem"},{"key":"36214_CR68","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1242\/jcs.114231","volume":"126","author":"N Hu","year":"2013","unstructured":"Hu, N. et al. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J Cell Sci 126, 532\u2013541, https:\/\/doi.org\/10.1242\/jcs.114231 (2013).","journal-title":"J Cell Sci"},{"key":"36214_CR69","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ijc.10719","volume":"102","author":"RC Haydon","year":"2002","unstructured":"Haydon, R. C. et al. Cytoplasmic and\/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer 102, 338\u2013342, https:\/\/doi.org\/10.1002\/ijc.10719 (2002).","journal-title":"Int J Cancer"},{"key":"36214_CR70","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1159\/000471945","volume":"41","author":"J Liao","year":"2017","unstructured":"Liao, J. et al. Notch Signaling Augments BMP9-Induced Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells (MSCs). Cell Physiol Biochem 41, 1905\u20131923, https:\/\/doi.org\/10.1159\/000471945 (2017).","journal-title":"Cell Physiol Biochem"},{"key":"36214_CR71","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3892\/ijo.2010.858","volume":"38","author":"BC He","year":"2011","unstructured":"He, B. C. et al. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt\/ss-catenin signaling. Int J Oncol 38, 437\u2013445, https:\/\/doi.org\/10.3892\/ijo.2010.858 (2011).","journal-title":"Int J Oncol"},{"key":"36214_CR72","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1159\/000447797","volume":"39","author":"Y Deng","year":"2016","unstructured":"Deng, Y. et al. A Blockade of IGF Signaling Sensitizes Human Ovarian Cancer Cells to the Anthelmintic Niclosamide-Induced Anti-Proliferative and Anticancer Activities. Cell Physiol Biochem 39, 871\u2013888, https:\/\/doi.org\/10.1159\/000447797 (2016).","journal-title":"Cell Physiol Biochem"},{"key":"36214_CR73","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 364, 2507\u20132516, https:\/\/doi.org\/10.1056\/NEJMoa1103782 (2011).","journal-title":"N Engl J Med"},{"key":"36214_CR74","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1158\/1535-7163.MCT-10-0368","volume":"9","author":"K Ketola","year":"2010","unstructured":"Ketola, K., Vainio, P., Fey, V., Kallioniemi, O. & Iljin, K. Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells. Mol Cancer Ther 9, 3175\u20133185, https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0368 (2010).","journal-title":"Mol Cancer Ther"},{"key":"36214_CR75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4046\/trd.2013.75.1.9","volume":"75","author":"HS Choi","year":"2013","unstructured":"Choi, H. S. et al. Autophagy Inhibition with Monensin Enhances Cell Cycle Arrest and Apoptosis Induced by mTOR or Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cells. Tuberc Respir Dis (Seoul) 75, 9\u201317, https:\/\/doi.org\/10.4046\/trd.2013.75.1.9 (2013).","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"36214_CR76","first-page":"855","volume":"22","author":"WH Park","year":"2003","unstructured":"Park, W. H. et al. Monensin inhibits the growth of renal cell carcinoma cells via cell cycle arrest or apoptosis. Int J Oncol 22, 855\u2013860 (2003).","journal-title":"Int J Oncol"},{"key":"36214_CR77","first-page":"377","volume":"22","author":"WH Park","year":"2003","unstructured":"Park, W. H., Kim, E. S., Jung, C. W., Kim, B. K. & Lee, Y. Y. Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis. Int J Oncol 22, 377\u2013382 (2003).","journal-title":"Int J Oncol"},{"key":"36214_CR78","first-page":"197","volume":"23","author":"WH Park","year":"2003","unstructured":"Park, W. H., Kim, E. S., Kim, B. K. & Lee, Y. Y. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. Int J Oncol 23, 197\u2013204 (2003).","journal-title":"Int J Oncol"},{"key":"36214_CR79","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ijc.10592","volume":"101","author":"WH Park","year":"2002","unstructured":"Park, W. H. et al. Monensin-mediated growth inhibition in acute myelogenous leukemia cells via cell cycle arrest and apoptosis. Int J Cancer 101, 235\u2013242, https:\/\/doi.org\/10.1002\/ijc.10592 (2002).","journal-title":"Int J Cancer"},{"key":"36214_CR80","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1365-2141.2002.03834.x","volume":"119","author":"WH Park","year":"2002","unstructured":"Park, W. H. et al. Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis. Br J Haematol 119, 400\u2013407 (2002).","journal-title":"Br J Haematol"},{"key":"36214_CR81","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1158\/1535-7163.MCT-13-0625","volume":"13","author":"L Tumova","year":"2014","unstructured":"Tumova, L. et al. Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice. Mol Cancer Ther 13, 812\u2013822, https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0625 (2014).","journal-title":"Mol Cancer Ther"},{"key":"36214_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-10-84","volume":"10","author":"BM Chung","year":"2009","unstructured":"Chung, B. M. et al. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src. BMC Cell Biol 10, 84, https:\/\/doi.org\/10.1186\/1471-2121-10-84 (2009).","journal-title":"BMC Cell Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36214-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36214-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T12:23:19Z","timestamp":1671625399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-36214-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["36214"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-36214-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,17]]},"assertion":[{"value":"5 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17914"}}